Data as of 4:00pm ET
| +0.09 / +0.13%|
The 4 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 110.00, with a high estimate of 147.00 and a low estimate of 81.08. The median estimate represents a +56.43% increase from the last price of 70.32.
The current consensus among 4 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.